|
|
|
41
|
77013
|
GOTABIOTIC F 0.1%|0.3% EYE DR (LPO) DEXAMETHASONE|TOBRAMYCIN (C)
|
DEXAMETHASONE|TOBRAMYCIN
|
GOTABIOTIC F
|
5ML
|
C
|
7.58
|
7.5841
|
BOTT
|
0
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
7701D
|
DEXAMETHASONE/TOBRAMYCIN EYE DR (CIR/AHI)
|
DEXAMETHASONE|TOBRAMYCIN
|
DEXAMETHASONE|TOBRAMYCIN
|
5ML
|
BQ
|
5.16
|
5.16
|
EYE DROP
|
0
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
7701D
|
DEXAMETHASONE|TOBRAMYCIN 0.1%|0.3% EYE DR (CIR) (BQ)
|
DEXAMETHASONE|TOBRAMYCIN
|
DEXAMETHASONE|TOBRAMYCIN
|
5ML
|
BQ
|
5.16
|
5.1648
|
BOTT
|
0
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
7701E
|
DEXAMETHASONE/TOBRAMYCIN EYE DR (KWA/ATB)
|
DEXAMETHASONE|TOBRAMYCIN
|
DEXAMETHASONE|TOBRAMYCIN
|
5ML
|
BQ
|
5.41
|
5.41
|
EYE DROP
|
0
|
BOTT
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
7701H
|
TOBRADEX 0.1% | 0.3% EYE DR (NVS/COL) DEXAMETHA
|
DEXAMETHASONE|TOBRAMYCIN
|
TOBRADEX
|
5ML
|
C
|
21.09
|
21.09
|
EYE DROP
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
7701H
|
TOBRADEX 0.1%|0.3% EYE DR (NVS) DEXAMETHASONE|TOBRAMYCIN (C)
|
DEXAMETHASONE|TOBRAMYCIN
|
TOBRADEX
|
5ML
|
C
|
23.79
|
23.7853
|
BOTT
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
7701H
|
TOBRADEX 0.1%|0.3% EYE DR (NVS) DEXAMETHASONE|TOBRAMYCIN
|
DEXAMETHASONE|TOBRAMYCIN
|
TOBRADEX
|
5ML
|
C
|
23.79
|
23.79
|
BOTT
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
OPHTHALMIC
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
7701J
|
TOBAGRAM D 0.1%|0.3% EYE DR (HAN) DEXAMETHASONE|TOBRAMYCIN (BQ)
|
DEXAMETHASONE|TOBRAMYCIN
|
TOBAGRAM D
|
10ML
|
BQ
|
4.27
|
4.2678
|
BOTT
|
0
|
BOTT
|
HAN
|
HANUCHEM LABORATORIES
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
7701J
|
TOBAGRAM D 0.1%|0.3% EYE DR (HAN) DEXAMETHASONE|TOBRAMYCIN
|
DEXAMETHASONE|TOBRAMYCIN
|
TOBAGRAM D
|
10ML
|
BQ
|
4.30
|
4.29
|
BOTT
|
0
|
BOTT
|
HAN
|
HANUCHEM LABORATORIES
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
OPHTHALMIC
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
77022
|
GOTABIOTIC F EYE OINT (LPO/COL) DEXAMETHASON
|
DEXAMETHASONE|TOBRAMYCIN
|
GOTABIOTIC F
|
3.5G
|
C
|
11.69
|
11.69
|
EYE OINTMENT
|
0
|
TUBE
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
77022
|
GOTABIOTIC F EYE OINT (LPO) DEXAMETHASO (C)
|
DEXAMETHASONE|TOBRAMYCIN
|
GOTABIOTIC F
|
3.5G
|
C
|
12.86
|
12.8577
|
TUBE
|
0
|
BOX
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
77025
|
T-MYCIN PLUS EYE OINT (ARP/AHI) DEXAMETHASON
|
DEXAMETHASONE|TOBRAMYCIN
|
T-MYCIN PLUS
|
3.5G
|
BQ
|
7.12
|
7.12
|
EYE OINTMENT
|
0
|
TUBE
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
77027
|
TOBRADEX 0.1% | 0.3% EYE OINT (NVS/COL) DEXAMET
|
DEXAMETHASONE|TOBRAMYCIN
|
TOBRADEX
|
3.5G
|
C
|
23.73
|
23.73
|
EYE OINTMENT
|
0
|
TUBE
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
77027
|
TOBRADEX 0.1%|0.3% EYE OINT (NVS) D (C)
|
DEXAMETHASONE|TOBRAMYCIN
|
TOBRADEX
|
3.5G
|
C
|
23.73
|
23.731
|
TUBE
|
1
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
77027
|
TOBRADEX 0.1%|0.3% EYE OINT (NVS) DEXAMETHASONE|TOBRAMYCIN
|
DEXAMETHASONE|TOBRAMYCIN
|
TOBRADEX
|
3.5G
|
C
|
23.73
|
23.73
|
TUBE
|
1
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
77028
|
TOBAGRAM D 0.1%|0.3% EYE DR (SPC) DEXAMETHASONE|TOBRAMYCIN (BQ)
|
DEXAMETHASONE|TOBRAMYCIN
|
TOBAGRAM D
|
5G
|
BQ
|
4.27
|
4.2678
|
TUBE
|
1
|
TUBE
|
SPC
|
SELVOK PHARMACEUTICALS CO
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
77028
|
TOBAGRAM D 0.1%|0.3% EYE OINT (SPC) DEXAMETHASONE|TOBRAMYCI
|
DEXAMETHASONE|TOBRAMYCIN
|
TOBAGRAM D
|
5G
|
B
|
4.40
|
4.40
|
TUBE
|
1
|
TUBE
|
SPC
|
SELVOK PHARMACEUTICALS CO
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|